DAP CEO Codrin Arsene Shares Why AI Is a Pharma Marketing Game Changer
Artificial intelligence (AI) has become instrumental in transforming various sectors of healthcare in recent years and pharmaceutical marketing is no exception.
Recently, our CEO Codrin Arsene shared his insights on the effectiveness of AI for pharma marketing in PM360, a premier publication for marketing decision makers in pharmaceutical, biotech, and medical devices industries.
As Arsene puts it,
In pharma marketing, AI is a game changer.
A powerful driving force behind marketing automation, AI can perform social listening, pinpoint the right key opinion leaders, and generate marketing copy that outperforms that of humans.
We’ve seen the applications of this technology first-hand by using it to help our clients achieve impressive and quantifiable results.
In 2014, we helped a large retailer achieve a 500% growth in web sales conversion almost overnight by leveraging AI-powered social listening tools to crawl customers’ Twitter and Facebook conversations.
Imagine the kind of impact this technology can have on pharmaceutical marketing.
AI can help pharma companies deliver targeted outreach at scale by interpreting large data sets, responding to ongoing data changes, and deploying far-reaching strategies in the moment.
Coupled with a strategic healthcare marketing plan, AI-powered marketing automation can help pharma companies facilitate the right conversations with physicians and patients at the right time to drive optimal results.
Curious to learn more about AI in pharma? Read our in-depth article here.
Related articles
“Digital Authority Partners is the definition of an entrepreneur success story.” In his interview with SuperbCrew, DA...
How will AI help or hinder entrepreneurship? DAP’s CEO, Codrin Arsene, talks with Enterprise Radio’s Eric...
Building a successful business requires more than hard work. It’s an entrepreneur’s ability to overcome obstacles and...
